Feasibility of quality of life assessment in patients with upper gastrointestinal tract cancer

被引:0
作者
J M Blazeby
J Nicklin
S T Brookes
K Winstone
D Alderson
机构
[1] Bristol Royal Infirmary,University Division of Surgery
[2] University of Bristol,Department of Social Medicine
来源
British Journal of Cancer | 2003年 / 89卷
关键词
quality of life; EORTC QLQ-C30; compliance; upper gastrointestinal cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Quality of life (QOL) is an important outcome after treatment for upper gastrointestinal tract cancer but few studies report good accrual and subsequent attrition is usually high. This study investigated the feasibility of a nurse-led service to obtain longitudinal QOL assessments and explored how clinical and sociodemographic factors influence patients' need for help to complete questionnaires. Fully informed patients were invited into the study. Baseline hospital assessments were scheduled by telephone and thereafter by post unless patients' health indicated the need for a home visit. In all, 128 out of 140 (91%) baseline QOL assessments were performed. Follow-up questionnaire completion was good, with 114 patients (89%) completing all but one of the expected assessments. At baseline, 41 (32%) patients required a lot of help to complete questionnaires. Patients requiring help were more likely to be undergoing palliative treatment than treatment aimed at cure (68 vs 33%; odds ratio 3.48, P<0.01). Patients' with advanced stage cancer of the upper gastrointestinal tract receiving palliative treatment require dedicated staff to ensure good compliance with longitudinal QOL data collection. It is essential to budget for this in clinical trails.
引用
收藏
页码:497 / 501
页数:4
相关论文
共 140 条
[1]  
Aaronson NK(1993)The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology J Nat Cancer Inst 85 365-376
[2]  
Ahmedzai S(1991)Prospective quality-of-life analysis after palliative photoablation for the treatment of malignant dysphagia Cancer 68 1660-1664
[3]  
Bergman B(2001)Clinical relevance of single item quality of life indicators in cancer clinical trials Br J Cancer 84 1156-1165
[4]  
Bullinger M(1996)Development of a EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer Eur J Cancer 32 1912-1917
[5]  
Cull A(2003)Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer Eur J Cancer 39 1384-1394
[6]  
Duez NJ(2000)Quality of life evaluation in oncological clinical trials–the EORTC model Eur J Cancer 36 821-825
[7]  
Filiberti A(1998)Quality of life assessment in daily clinical oncology practise: a feasibility study Eur J Cancer 34 1181-1186
[8]  
Flechtner H(2000)How are you feeling? Who wants to know? Patients' and oncologists' preferences for discussing health-related quality-of-life issues J Clin Oncol 18 3295-3301
[9]  
Fleishman SB(1997)Outcome measures in palliative care for advanced cancer patients: a review J Public Health Med 19 193-199
[10]  
De Haes JCJM(1999)Phase 2 trial of weekly irinotecan plus cisplatin in advanced esophageal cancer J Clin Oncol 17 3270-3275